Consensus & Practice-Changing Papers
- Neoadjuvant chemoradiotherapy plus surgery vs surgery alone fo oesophageal or junctional cancer (CROSS): long term results of a randomised controlled trial. Shapiro, van Lanschot, et al. Lanc Onc 2015
- Updated analysis of SWOG-directed intergroup study 0116: phase III trial of adjuvant radiochemotherapy vs observation after curative gastric cancer resection. Smalley, Benedetti, et al. J Clin Oncol 2012
- Integrated genomic characterization of esophageal carcinoma. Cancer Genome Atlas Research Network. Nature 2017
- Comprehensive molecular characterization of gastric adenocarcinoma. Cancer Genome Atlas Research Network. Nature 2014
- Updated analysis of SWOG-directed intergroup study 0116: phase III trial of adjuvant radiochemotherapy vs observation after curative gastric cancer resection. Smalley, Benedetti, et al. J Clin Oncol 2012
- Perioperative chemotherapy vs surgery along for resectable gastroesophageal cancer. Cunningham, Allum, et al. N Engl J Med 2006
- Predicting aggressive behavior in non functioning pancreatic neuroendocrine tumors. Cherenfant, Stocker, et al. Surgery 2013
- Population-level analysis of pancreatic neuroendocrine tumors 2 cm of less in size. Kuo, Salem. Ann Surg Oncol 2013
- Surgical resection provides overall survival benefit for patients with small pancreatic neuroendocrine tumors. Sharpe, In, et al. J Gastrointest Surg 2015
- Operative vs nonoperative management of non functioning pancreatic neuroendocrine tumors. Zhang, Zhao, et al. J Gastrointest Surg 2016
- Correlation of kinase genotype and clinical outcome in North American Intergroup Phase III trial of imatinib mesylate for treatment of advance GIST: CALGB 150105. Heinrich, Owzar, et al. J Clin Oncol 2008
- Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. Raut, Posner, et al. J Clin Oncol 2006